期刊文献+

合并抗磷脂抗体相关性肾病慢性损伤的狼疮性肾炎39例临床分析 被引量:4

Clinical characteristics of thirty-nine cases of lupus nephritis with chronic histopathologic lesion of antiphospholipid antibody associated nephropathy
下载PDF
导出
摘要 目的观察抗磷脂抗体相关性肾病(APLN)慢性肾组织病理损伤患者有别于狼疮性肾炎的临床特征。方法回顾性分析北京协和医院2000年后196例狼疮性肾炎患者的临床特点及预后。分为对照组:APL阴性且无APLN肾组织病理损伤(119例);研究组:合并APLN慢性肾组织病理损伤狼疮性肾炎患者(39例)。另38例为APL阴性合并APLN慢性损伤样病变患者。结果研究组与对照组患者的血压为138±29/85±19 vs 96±17 mmHg,肾活检时血肌酐为99±39 vs 91±42μmol/L,估算的肾小球滤过率(eGFR)为72.7±30.0 vs 87.8±24.0 mL/min.1.73 m2。随诊2年时血肌酐为93±26 vs 80±18μmol/L。研究组的血压(包括收缩压、平均动脉压)较对照组更高、eGFR更低。两因素重复测量方差分析表明,随诊2年后研究组患者的血肌酐改善程度明显差于对照组(P<0.05)。结论合并APLN慢性损伤的狼疮性肾炎患者的血压更高,eGFR更低,肾脏预后较差。 Objective To investigate the clinical characteristics that differentiate chronic histopathologic lesion of antiphospholipid antibody associated nephropathy (APLN) from lupus nephritis. Methods Data of 196 cases of lu- pus nephritis admitted to Peking Union Medical College Hospital was reviewed by retrospective analysis. 39 cases of lupus nephritis with chronic APLN were enrolled into the study group. The control group was composed of 119 cases of lupus nephritis without antiphospholipid antibody (APL) and APLN. Other 38 cases had negative APL and chro- nic lesion of APLN-Iike renal lesions. Results The blood pressure and the serum creatinine level at biopsy and two years later in the study group and the control group were 138 ± 29/85 ± 19 vs 96 ± 17 mmHg, 99 ± 39 vs 91± 42 μmoL/L and 93 ±26 vs 80 ± 18 μ mol/L, respectively. Estimated GFR (eGFR) at biopsy was 72. 7 ± 30. 0 vs 87. 8 =1= 24. 0 mL/min ± 1.73 m2. The blood pressure including systolic, mean arterial pressure and the eGFR at bi- opsy was significantly higher in the study group compared with the control group. Two-way repeated measures ANOVA showed the serum creatinine levels two years later in the study group decreased obviously less than that in the control group (P 〈 0. 05 ). Conclusions Lupus nephritis patients with chronic histopathologic lesion of APLN had higher blood pressure, lower eGFR and relatively poor renal prognosis.
出处 《基础医学与临床》 CSCD 北大核心 2013年第5期618-622,共5页 Basic and Clinical Medicine
基金 国家(重点)实验室专项经费(2060204) 北京协和医院2010年度院内青年基金(2010129)
关键词 系统性红斑狼疮 抗磷脂抗体 抗磷脂抗体相关性肾病 systemic lupus erythematosus antiphospholipid antibody antiphoslipid antibody associated nephropathy
  • 相关文献

参考文献13

  • 1Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification crite- ria for definite antiphospholipid syndrome (APS) [ J ]. J Thromb Haemost, 2006,4:295 - 306.
  • 2高瑞通,俞文清,文煜冰,李雪梅,郑法雷.系统性红斑狼疮合并抗磷脂抗体相关性肾病的肾组织病理学特点[J].基础医学与临床,2011,31(12):1387-1391. 被引量:5
  • 3Weening JJ, D'Agati VD, Schwartz MM, et al. The classi- fication of glomerulonephritis in systemic lupus erythemato- sus revisited[J]. Kidney Int, 2004,65:521 -530.
  • 4MC H. Updating the American College of Rheumatology re- vised criteria for the classification of systemic lupus erythe- matosus [ J ]. Arthritis Rheum, 1997,40 : 1725.
  • 5Daugas E, Nochy D, Huong DL, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus [ J ]. J Am Soc Nephrol, 2002,13:42 -52.
  • 6Silvarino R, Sant F, Espinosa G, et al. Nephropathy asso- ciated with antiphospholipid antibodies in patients with sys- temic lupus erythematosus [ J ]. Lupus, 2011. 20 : 721 - 729.
  • 7Sinico RA, Cavazzana I, Nuzzo M, et al. Renal involve- ment in primary antiphospholipid syndrome: retrospective a- nalysis of 160 patients[J]. Clin J Am Soc Nephrol, 2010, 5:1211 - 1217.
  • 8Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome [J]. J Am Soc Nephrol, 1999,10:507 -518.
  • 9高瑞通,孙阳,郑法雷.抗磷脂综合征的肾损害[J].中华肾脏病杂志,2005,21(6):320-323. 被引量:12
  • 10俞雯清,文煜冰,高瑞通,李航,李雪梅.系统性红斑狼疮并发继发性抗磷脂综合征肾损害11例临床病理分析[J].中华肾脏病杂志,2010,26(12):875-879. 被引量:6

二级参考文献48

  • 1冷晓梅,刘晓敏,艾脉兴,曾小峰,唐福林.抗磷脂综合征61例临床分析[J].中华医学杂志,2004,84(16):1367-1370. 被引量:18
  • 2高瑞通,孙阳,郑法雷.抗磷脂综合征的肾损害[J].中华肾脏病杂志,2005,21(6):320-323. 被引量:12
  • 3Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification eriteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum, 1999, 42: 1309-1311.
  • 4Nzerue CM, Hewan-Lowe K, Pierangeli S, et al. "Black in the kidney": renal involvement in the antiphospholipid antibody syndrome. Kidney lnt, 2002, 62: 733 -744.
  • 5Vigneau C, Daugas E, Maury E, et al. Renal cortical necrosis related to paraneoplastic antiphospholipid syndrome. Am J Kidney Dis, 2006, 47: 1072-1074.
  • 6Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus, 2003, 12: 530-534.
  • 7Asherson RA, Cervera R. Primary, secondary and other variants of the antiphospholipid syndrome. Lupus, 1994, 3: 293 -298.
  • 8Bucciarelli S, Erkan D, Espinosa G, et ah Catastrophic antiphospholipid syndrome:treatment, prognosis, and the risk of relapse. Clin Rev Allergy hnmunol, 2009, 36: 80-84.
  • 9Cervera R, Buceiarelli S, Plasln MA, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the CAPS Registry. J Autoimmun, 2009, 32: 240-24-5.
  • 10Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rhemn, 1999, 42: 1309-1311.

共引文献19

同被引文献103

引证文献4

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部